Blog

Jun 26, 2019

Surprise patent ruling revives high-stakes dispute over the genome editor CRISPR

Posted by in categories: biotech/medical, innovation

U.S. patent officials reexamining claims about who deserves rights to enormously valuable aspect of the invention.

Leave a reply